ÂÜŔňÂŇÂ×

Sarah Alspach joined the flock in September 2021 as Chief Communications Officer. Sarah oversees corporate communications, investor relations, and patient advocacy and is focused on driving bluebird’s external engagement as we pursue curative gene therapies for severe genetic diseases.

Prior to joining bluebird, Sarah served as Senior Vice President and Chief Communications Officer for the Cystic Fibrosis Foundation, the world’s leader in the search for a cure for cystic fibrosis. She also spent more than a decade at GlaxoSmithKline (GSK) where she was Vice President for U.S. Pharma and Corporate Communications, with responsibility for communications, corporate brand and reputation, and philanthropic giving in the US. Sarah holds a B.S. in public relations from the University of Texas at Austin and lives outside of Washington, DC with her husband and three children.